
Beetaz-P 4gm/0.5gm Injection
Marketer
Biocin Genetics & Pharma
Salt Composition
Piperacillin (4gm) + Tazobactum (0.5gm)
Overview Beetaz-P 4gm/0.5gm Injection
Beetaz-P 4gm/0.5gm Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity, requiring precise adherence to their prescribed regimen. Common side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; adjustments to dosage or alternative medications may be necessary. Generally considered safe during pregnancy and lactation under medical guidance.
Uses of Beetaz-P 4gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Beetaz-P 4gm/0.5gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Beetaz-P 4gm/0.5gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Beetaz-P 4gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Beetaz-P 4gm/0.5gm Injection works:
Beetaz-P Injection (4gm piperacillin/0.5gm tazobactam) combines piperacillin, a bacterial cell wall synthesis inhibitor antibiotic, with tazobactam, a beta-lactamase inhibitor. Tazobactam's action protects piperacillin from inactivation, thereby boosting its antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Beetaz-P 4gm/0.5gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation Beetaz-P (4gm/0.5gm) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent negative impacts on fetal development; nonetheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Beetaz-P (4gm/0.5gm) poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, suggesting negligible harm to infants.
DrivingCONSULT YOUR DOCTOR
The effect of Beetaz-P 4gm/0.5gm Injection on driving ability is unknown. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Beetaz-P 4gm/0.5gm Injection cautiously, potentially requiring a modified dosage. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Beetaz-P 4gm/0.5gm Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Beetaz-P 4gm/0.5gm Injection :
Omitting a scheduled dose of Beetaz-P 4gm/0.5gm Injection warrants immediate physician consultation.
Facts to Know About Beetaz-P 4gm/0.5gm Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial Agents |
